A study of the alternating administration of ixabepilone and vinflunine every three weeks in patients with advanced cancer

Trial Profile

A study of the alternating administration of ixabepilone and vinflunine every three weeks in patients with advanced cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 16 May 2008

At a glance

  • Drugs Ixabepilone; Vinflunine
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 16 May 2008 Status changed from in progress to completed.
    • 25 Apr 2008 Planned patient number and estimated study completion date updated from ClinicalTrials.gov
    • 07 Mar 2008 Status changed from recruiting to in progress, according to ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top